Cambridge Cognition yesterday announced its expansion into China, the World's second largest clinical trial market. The Chinese foray is through a strategic partnership with Shanghai based Luca Healthcare, a leading player in digital screening, treatment, and management tools.
25 Nov 2022
Expansion into China
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Expansion into China
Cambridge Cognition Holdings Plc (COG:LON) | 52.0 0 0.0% | Mkt Cap: 18.3m
- Published:
25 Nov 2022 -
Author:
Brendan D'Souza | Paul David Richards -
Pages:
6
Cambridge Cognition yesterday announced its expansion into China, the World's second largest clinical trial market. The Chinese foray is through a strategic partnership with Shanghai based Luca Healthcare, a leading player in digital screening, treatment, and management tools.